285 related articles for article (PubMed ID: 11425765)
1. Deficiency of tissue factor pathway inhibitor promotes atherosclerosis and thrombosis in mice.
Westrick RJ; Bodary PF; Xu Z; Shen YC; Broze GJ; Eitzman DT
Circulation; 2001 Jun; 103(25):3044-6. PubMed ID: 11425765
[TBL] [Abstract][Full Text] [Related]
2. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
3. Presence of tissue factor pathway inhibitor in human atherosclerotic plaques is associated with reduced tissue factor activity.
Caplice NM; Mueske CS; Kleppe LS; Simari RD
Circulation; 1998 Sep; 98(11):1051-7. PubMed ID: 9736590
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery.
Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
Blood; 2000 Dec; 96(13):4212-5. PubMed ID: 11110693
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor pathway inhibitor deficiency enhances neointimal proliferation and formation in a murine model of vascular remodelling.
Singh R; Pan S; Mueske CS; Witt TA; Kleppe LS; Peterson TE; Caplice NM; Simari RD
Thromb Haemost; 2003 Apr; 89(4):747-51. PubMed ID: 12669131
[TBL] [Abstract][Full Text] [Related]
6. Conditional knockout of TFPI-1 in VSMCs of mice accelerates atherosclerosis by enhancing AMOT/YAP pathway.
Xiao J; Jin K; Wang J; Ma J; Zhang J; Jiang N; Wang H; Luo X; Fei J; Wang Z; Yang X; Ma D
Int J Cardiol; 2017 Feb; 228():605-614. PubMed ID: 27875740
[TBL] [Abstract][Full Text] [Related]
7. Hyperlipidemia promotes thrombosis after injury to atherosclerotic vessels in apolipoprotein E-deficient mice.
Eitzman DT; Westrick RJ; Xu Z; Tyson J; Ginsburg D
Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1831-4. PubMed ID: 10894825
[TBL] [Abstract][Full Text] [Related]
8. CCL5 deficiency reduces neointima formation following arterial injury and thrombosis in apolipoprotein E-deficient mice.
Czepluch FS; Meier J; Binder C; Hasenfuss G; Schäfer K
Thromb Res; 2016 Aug; 144():136-43. PubMed ID: 27337700
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice.
Zhu Y; Farrehi PM; Fay WP
Circulation; 2001 Jun; 103(25):3105-10. PubMed ID: 11425776
[TBL] [Abstract][Full Text] [Related]
10. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
[TBL] [Abstract][Full Text] [Related]
11. Role for tissue factor pathway in murine model of vascular remodeling.
Singh R; Pan S; Mueske CS; Witt T; Kleppe LS; Peterson TE; Slobodova A; Chang JY; Caplice NM; Simari RD
Circ Res; 2001 Jul; 89(1):71-6. PubMed ID: 11440980
[TBL] [Abstract][Full Text] [Related]
12. Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries.
Golino P; Cirillo P; Calabro' P; Ragni M; D'Andrea D; Avvedimento EV; Vigorito F; Corcione N; Loffredo F; Chiariello M
J Am Coll Cardiol; 2001 Aug; 38(2):569-76. PubMed ID: 11499754
[TBL] [Abstract][Full Text] [Related]
13. The extrinsic coagulation cascade and tissue factor pathway inhibitor in macrophages: a potential therapeutic opportunity for atherosclerotic thrombosis.
Jiang P; Xue D; Zhang Y; Ye L; Liu Y; Makale M; Kesari S; Edgington TS; Liu C
Thromb Res; 2014 Apr; 133(4):657-66. PubMed ID: 24485401
[TBL] [Abstract][Full Text] [Related]
14. The effect of vascular smooth muscle cell-targeted expression of tissue factor pathway inhibitor in a murine model of arterial thrombosis.
Pan S; Kleppe LS; Witt TA; Mueske CS; Simari RD
Thromb Haemost; 2004 Sep; 92(3):495-502. PubMed ID: 15351845
[TBL] [Abstract][Full Text] [Related]
15. Murine hematopoietic cell tissue factor pathway inhibitor limits thrombus growth.
Maroney SA; Cooley BC; Ferrel JP; Bonesho CE; Mast AE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):821-6. PubMed ID: 21233452
[TBL] [Abstract][Full Text] [Related]
16. Factor XI regulates pathological thrombus formation on acutely ruptured atherosclerotic plaques.
van Montfoort ML; Kuijpers MJ; Knaup VL; Bhanot S; Monia BP; Roelofs JJ; Heemskerk JW; Meijers JC
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1668-73. PubMed ID: 24947525
[TBL] [Abstract][Full Text] [Related]
17. Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice.
Hoving S; Heeneman S; Gijbels MJ; Te Poele JA; Visser N; Cleutjens J; Russell NS; Daemen MJ; Stewart FA
Radiother Oncol; 2012 Dec; 105(3):365-70. PubMed ID: 23245647
[TBL] [Abstract][Full Text] [Related]
18. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury.
Ragni M; Golino P; Cirillo P; Scognamiglio A; Piro O; Esposito N; Battaglia C; Botticella F; Ponticelli P; Ramunno L; Chiariello M
Circulation; 2000 Jul; 102(1):113-7. PubMed ID: 10880423
[TBL] [Abstract][Full Text] [Related]
19. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries.
Atsuchi N; Nishida T; Marutsuka K; Asada Y; Kamikubo Y; Takeshita A; Ueno H
Circulation; 2001 Jan; 103(4):570-5. PubMed ID: 11157724
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice.
Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W
J Pathol; 2001 Sep; 195(2):257-63. PubMed ID: 11592107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
